QC
IRWD icon

Quent Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Quent Capital’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-24,500
Closed -$101K – 1383
2024
Q3 		$101K Hold
24,500
– – 0.01% 501
2024
Q2 		$160K Hold
24,500
– – 0.02% 356
2024
Q1 		$213K Hold
24,500
– – 0.02% 311
2023
Q4 		$280K Hold
24,500
– – 0.04% 241
2023
Q3 		$236K Hold
24,500
– – 0.04% 245
2023
Q2 		$261K Hold
24,500
– – 0.04% 234
2023
Q1 		$255K Hold
24,500
– – 0.04% 230
2022
Q4 		$304K Hold
24,500
– – 0.06% 199
2022
Q3 		$254K Buy
+24,500
New +$278K 0.05% 208

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Quent Capital's IRWD Position: Q4 2024 in Review

Quent Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 24,500 shares — an estimated $101K sold.

Quent Capital first reported a position in IRWD in Q3 2022 and held it in 9 quarters. The position peaked at $304K in Q4 2022. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • Quent Capital reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Quent Capital sold 24,500 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $101K.
  • Quent Capital first reported a position in Ironwood Pharmaceuticals in Q3 2022 and held it in 9 quarters.
  • Quent Capital's Ironwood Pharmaceuticals position peaked at $304K in Q4 2022.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Quent Capital's 13F filing for Q4 2024, filed 29 Jan 2025.